ACQUISITION DE L’ACTIVITÉ ARGATROBAN EN EUROPE

SAINT-CLOUD, France, 18 juin 2024 /PRNewswire/ — Ethypharm a conclu un accord avec Mitsubishi Tanabe Pharma Corporation (MTPC) pour acquérir l’agent antithrombin sélectif, Argatroban monohydrate (Argatra®, Arganova®, Novastan®, Exembol®), en Europe. Ethypharm, connue pour son expertise…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.